Topic: schizophrenia drug
The FDA requested the delay after seeing data from studies of glutamate inhibitor evenamide in mice and dogs.
Boston startup Karuna Therapeutics has raised a chunky $68 million as it looks to beef up work on its Alzheimer’s/schizophrenia combo therapy.
BI 409306 failed to show superiority over placebo in cognition across a midphase program that enrolled 457 patients with early signs of Alzheimer’s.
Boehringer is paying €25 million upfront and committing to up to €600 million more to land an option on Autifony’s schizophrenia drug.
The approval clears Otsuka to start selling a sensor-enabled version of its schizophrenia drug Abilify designed to improve compliance.
Phase 2a data for Newron's schizophrenia drug evenamide due in March should help the company sign a development partner later this year, says CEO.